Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Tue 12 May 2009, 14:29 MDC - Medi-Clinic - Trading Statement
MDC
MDC                                                                             
MDC - Medi-Clinic - Trading Statement                                           
MEDI-CLINIC CORPORATION LIMITED                                                 
(Incorporated in the Republic of South Africa)                                  
(Registration number: 1983/010725/06)                                           
(Share code: MDC)                                                               
(ISIN: ZAE000074142)                                                            
("Medi-Clinic" or "the Company")                                                
TRADING STATEMENT                                                               
The operational performance of Medi-Clinic for the financial year ended 31      
March 2009 is consistent with historical performance and expectations and is    
not the subject of this trading statement.                                      
In terms of paragraph 3.4(b) of the JSE Limited ("JSE") Listings Requirements,  
companies are required to publish a trading statement as soon as they become    
reasonably certain that the financial results for the period to be reported     
upon next will differ by at least 20% from that of the previous corresponding   
period.  Medi-Clinic is currently finalising its results for the financial      
year ended 31 March 2009, which are due to be released on SENS on 19 May 2009   
and published in the press on 20 May 2009.                                      
Shareholders are referred to the circular to shareholders dated 17 August 2007  
("the circular") presenting details relating to the acquisition of the          
Hirslanden private hospital group in Switzerland, which transaction became      
effective on 26 October 2007 (the "Hirslanden acquisition") and the rights      
offer of 198.7 million Medi-Clinic shares, effected in December 2007 (the       
"rights offer"). The unaudited pro forma financial effect of the Hirslanden     
acquisition and the rights offer on the earnings per share ("EPS") and the      
headline EPS ("HEPS") of the Company was fully disclosed in the circular.       
In compliance with the JSE Listings Requirements, shareholders are advised      
that the Company`s EPS and HEPS for the financial year ended 31 March 2009      
will be between 20% and 25% lower than that reported for the previous           
corresponding reporting period, mainly as a result of the increased weighted    
number of ordinary shares in issue pursuant to the rights offer.                
The financial information on which this trading statement is based has not      
been reviewed and reported on by the Company`s auditors.                        
Stellenbosch                                                                    
12 May 2009                                                                     
Sponsor                                                                         
RAND MERCHANT BANK (A division of FirstRand Bank Limited)                       
Date: 12/05/2009 14:29:01 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: